Cardiac resynchronization therapy restores muscular metaboreflex control

Area of Science:

• Cardiology
• Exercise Physiology
• Autonomic Nervous System Research

Background:

• The muscular metaboreflex, crucial for regulating blood flow during exercise, is impaired in heart failure (HF).
• Cardiac resynchronization therapy (CRT) is a potential intervention to restore this impaired reflex in HF patients.

Purpose of the Study:

• To investigate the effects of CRT on metaboreflex responses in patients with heart failure.
• To evaluate changes in muscle sympathetic nerve activity (MSNA) and functional capacity following CRT implantation.

Main Methods:

• Thirteen HF patients and 12 healthy controls underwent assessments including heart rate, blood pressure, forearm blood flow, MSNA, and peak oxygen consumption (VO2peak).
• Measurements were taken at rest, during isometric exercise, and during forearm ischemia to activate the metaboreflex, both pre- and post-CRT in HF patients.
• The primary outcome was the change in MSNA during limb ischemia compared to rest (ΔMSNA).

Main Results:

• CRT significantly decreased resting MSNA and MSNA during limb ischemia in HF patients.
• The increase in MSNA from rest to metaboreflex activation (ΔMSNA) was significantly enhanced post-CRT.
• CRT improved VO2peak, with this improvement correlating with reduced ΔMSNA at rest.

Conclusions:

• Cardiac resynchronization therapy sensitizes the metaboreflex and enhances muscle sympathetic nerve activity in heart failure patients.
• The restoration of sympathetic responsiveness following CRT is linked to improvements in functional capacity and exercise tolerance.